BUMP
发表于 2025-3-23 11:33:32
http://reply.papertrans.cn/19/1876/187535/187535_11.png
肥料
发表于 2025-3-23 14:30:32
Biologics in Crohn’s Disease and Ulcerative Colitis: Focus on Tumor Necrosis Factor Antagonistsnagement options for these diseases. The discovery of immunologic and inflammatory mediators, in particular, has paved the way for clinical research with biologic agents in this area. Although conventional treatments remain viable options for some patients, those who are intolerant to these agents a
Estrogen
发表于 2025-3-23 18:06:12
Multiple Sclerosis: New Immunobiologicsworldwide by this disease, and the relapsing-remitting form of MS exhibits a gender disequilibrium of 3:1 for female affliction. There are several lines of evidence that multiple sclerosis is an autoimmune disease, which may be modified by genetic factors (see review in .). Following the initial for
合唱团
发表于 2025-3-24 01:17:16
Biologics in Cutaneous Lymphomatracutaneous disease at the time of diagnosis. They can be distinguished into cutaneous T-cell lymphomas (CTCL), cutaneous B-cell lymphomas (CBCL) and the rare precursor dendritic cell neoplasms. The PCL are now classified in the new WHO-EORTC classification (.; Table 14.1).
Explicate
发表于 2025-3-24 04:16:15
http://reply.papertrans.cn/19/1876/187535/187535_15.png
Forage饲料
发表于 2025-3-24 08:47:31
http://reply.papertrans.cn/19/1876/187535/187535_16.png
温和女孩
发表于 2025-3-24 10:43:38
Summary and Critical Reflection of efficacy and/or safety problems like infusion reactions. Therefore, chimaeric antibodies such as infliximab (Remicade) were developed, reducing immunogenicity by replacement of the murine Fc part by the human counterpart.
字形刻痕
发表于 2025-3-24 15:39:32
http://reply.papertrans.cn/19/1876/187535/187535_18.png
Terminal
发表于 2025-3-24 20:37:49
http://reply.papertrans.cn/19/1876/187535/187535_19.png
隐士
发表于 2025-3-25 01:20:15
http://reply.papertrans.cn/19/1876/187535/187535_20.png